Explore the latest trends in cardiovascular health – from personalized medicine and precision interventions to the integration of genomics, AI, and telemedicine. Discover groundbreaking studies, recent clinical trial insights, and the transformative impact of wearable tech and digital platforms on risk assessment and disease management. Join us for a concise yet comprehensive session that bridges recent scientific breakthroughs with practical applications in cardiovascular care. Stay informed, stay ahead.

SUBTOPICS:

· Atrial Fibrillation

· Device Therapy

· Chronic Heart Failure

· Acute Heart Failure

· Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

· Acute Coronary Syndromes

· Acute Cardiac Care

· Valvular Heart Disease

· Myocardial Disease

· Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure

· Epidemiology of Heart Failure

· Update on Heart Failure Guidelines

· Update on Cardiovascular Risk Factors..... and more...

In this succinct scientific session on "Heart Regeneration," we unravel cutting-edge developments in the field. Recent strides in regenerative medicine offer promising avenues for cardiac tissue repair and rejuvenation. Explore breakthroughs in stem cell therapy, tissue engineering, and novel biomaterials facilitating heart regeneration. This session aims to provide a quick yet insightful overview of recent trends, paving the way for a future where cardiac regeneration becomes a reality. Join us for a brief exploration into the exciting frontier of heart regeneration research.

SUBTOPICS:

· Electrocardiogram (ECG or EKG) - Cardiology echo

· Holter monitoring

· Echocardiogram

· Stress test

· Cardiac catheterization

· Cardiac computerized tomography (CT) scan

· Cardiac magnetic resonance imaging (MRI)

· Coronary Artery Disease (CAD)

· Heart Arrhythmias

· Heart Failure

· Heart Valve Disease

· Pericardial Disease

· Cardiomyopathy (Heart Muscle Disease)

· Congenital Heart Disease

Series of Cardiology Research exclusively focuses on bringing recent advances from the field that are authentic and medically proven. Regular physical activity is more beneficial for cardio health. Physically activities lead to maintaining blood pressure, higher insulin sensitivity, and a favourable plasma lipoprotein profile. This annual cardiology meeting is a platform for postgraduate education and scientific work in the fields of cardiology, angiology, hypertension, stroke, vascular surgery, medications for cardiac, Cardio health diet and many more topics.

SUBTOPICS:

· Coagulation and Thrombosis

· Endothelial dysfunction; Clinical assessment

· NASH and other ectopic lipid diseases

· Chronic kidney disease and nephropathies

· Diabetes; macro- and microangiopathies

· Aneurysms and other non-atherosclerotic arteriopathies

· Nutrition, nutraceuticals

· Bariatric surgery

· Lipid-lowering therapies

· Anti-thrombotic therapies

· Anti-inflammatory therapies

· Prevention and treatment of cardiovascular disease; miscellaneous

· New lipid-lowering therapies

The size of the global market for cardiovascular devices was $54.3 billion in 2021, and it is anticipated to increase by 7.1% annually to reach $87.77 billion by 2028. (2022-2028). The world's ageing population and the increasing prevalence of chronic conditions like diabetes and obesity are what are driving the market for cardiovascular devices. On a global scale, more than 38% of people are obese or overweight. In affluent nations like North America and Europe, its incidence is notably high. Contrarily, cardiovascular disease is the main cause of death worldwide and accounts for at least 32% of all annual fatalities worldwide, or around 18 million people.

Evolution of the new cardiac technologies to monitor innovative devices and procedures for diagnosing and treating heart conditions includes:

· Google Glass

· Bioresorbable stents

· Leadless pacemaker

· Valve-in-valve procedure

· Protein patch for heart muscle growth

· Miniature Ventricular Assist Device

· Novel Embolic Protection to Prevent Strokes

· Organ Conformal Electronics

· Mitral Valve Modulation and Repair

· Cardiac Decellularization and Engineered Heart Tissue

· Small, Portable ECMO Devices

· Engineered Heart Valve

· Artificial Intelligence to Predict Cardiac Arrhythmias

· Magnetic Navigation and Robotic Systems

· Pluripotent Stem Cells and Transdifferentiated Cardiomyocytes

Did you know for every six seconds in the world someone dies due to complications of diabetes?

The important main modifiable risk factors for stroke:

· Diabetes

· Obesity and belly fat

· Manage the diabetes ABCs

· Maintain healthy lifestyle habits

New research shows that Obesity drives up to half of all Type 2 diabetes and according to the statistics, In 2019, 1.5 million deaths were directly caused by diabetes. Ways to prevent the onset of type 2 diabetes are healthy diet, regular exercise, maintaining a normal body weight, avoiding tobacco usage.

Interventional cardiology is the treatment based on catheter for structural heart diseases. Cardiologist may use one or a combination of these below techniques to identify and treat the patient’s heart condition.

SUBTOPICS:

Invasive Cardiology
Non-Invasive Cardiology
Interventional Cardiology
Potential Game-changing Interventional Technologies on the Expo Floor
Shorter DAPT Using New Generation DES
Safety Questions on Paclitaxel Coated Stents and Balloons
New TAVR Devices Seeking U.S. FDA Approval
TAVR Leaflet Thrombosis, Thickening is Benign
New COAPT Trial Data on MitraClip
Coronary Intervention
Coronary Intervention: Complications
Coronary Intervention: Primary and Acute PCI
Coronary Intervention: Mechanical Circulatory Support
Coronary Intervention: Restenosis
Non-coronary Cardiac Intervention

Several specific new technologies are 3D printing; CTCA; FFR; Precision cardiology; Robotics; Stereolithography; VR; Virtual Reality.

Nuclear cardiology is the study that diagnose and risk strategy of coronary artery disease, myocardial infarction, left ventricular function, detection of right-to-left shunt using nuclear imaging techniques. Nuclear medicine uses radioactive materials, radiotracers that is mostly injected into the blood, indrawn or enveloped.

Molecular cardiology brings the change in the era by using the molecular biology technique for diagnosis, prevention and treatment of cardio disease. Although this technique is still at the early stage, it has opened a promising avenue for controlling cardiovascular disease and understanding it.

Cardio-oncology is a rising subspecialty within internal medicine, and particularly in cardiology, which involves the prevention and management of cardiovascular injury from cancer therapies. A minor portion of the field focuses in diagnosing and managing primary/secondary tumours to the heart and the majority focuses on cardiotoxicity from radiotherapy, chemotherapy, and immunotherapy.

SUBTOPICS:

· Positron Emission Tomography

· Single-Photon Emission Computed Tomography

· Echocardiography

· Radioactive Tracer

· Myocardial Perfusion Imaging

· Cardiac Magnetic Resonance Imaging

· Cardiovascular System

· Heart Muscle Perfusion

· Computer Assisted Tomography

· Coronary Artery Disease

Pediatric Cardiology is responsible for performing diagnostic procedures and diagnosing congenital heart defects, in infants, children, and adolescents. The various types of Inflammatory Heart Diseases are Myocarditis; Kawasaki disease and Pericardial diseases. Infective endocarditis is a form of endocarditis resulting in the inflammation of the inner tissues of the heart. These are some of the main inflammatory defects in Babies' hearts. This Heart 2023 conference will help in B2B partnering between professionals and academicians in Heart.

Especially, Compared to Men, Heart disease is the key problem of ladies. According to the statistics, one woman per minute inflicts one in three deaths annually. Moreover, the opposite heart diseases, like Coronary Microvascular Disease and broken heart syndrome, conjointly cause a risk for girls. Overall, the importance of cardiac arrhythmias depends on the presence or absence of Structural Heart Disease. Cardiovascular diseases are the foremost cause of death among women in the states.

Cardiac nursing is a nursing specialty that works with patients who are suffering from various conditions of the cardiovascular system. Cardiac nurses works in treating patients conditions suffering from unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia according to the direction suggested by the cardiologist. Cardiac nurses also play a vital role in postoperative care on a surgical unit, stress test evaluations, cardiac and vascular monitoring, health assessments, etc. Cardiac nurses play important role in many different environment including coronary care units, cardiac catheterization, intensive care units, operating theatres, cardiac rehabilitation centres, clinical research, cardiac surgery wards, cardiovascular intensive care units, and cardiac medical wards.

SUBTOPICS:

· Anatomy & physiology

· Cardiac pacing

· Congenital heart defects

· Cardiovascular pharmacology

· Surgical procedures and cardiopulmonary bypass

· Cardiac transplantation

· Post-operative complications

· Family concerns

Cardiac regeneration is the repair of damaged heart tissue using stem cell and cell-free therapy. Reparative tools are made to restore and regenerate damaged heart tissue and its function, using the body's natural ability. The effective regenerative solutions restoration, renewing, and recycling of patients' own reparative capacity is found in both the patients and providers. In recent research, Researchers have come forward with a new innovation in which they used stem cell therapy for regenerating cardiac function in pediatric patients.

The following topics are welcome for research on this Research Topic:

· Genetic Fate Mapping in Heart Regeneration

· Nuclear dynamics during human heart growth

· Stem Cell Therapy

· Methods for direct cell replacement using hiPS-CMs or other cell types

· Novel approaches for direct cardiac reprogramming

· Identification of metabolic activities and regulators that could influence the cell cycle in cardiomyocytes

· Methods to activate signaling pathways that could stimulate the cell cycle in cardiomyocytes

· Identification of transcription factors that can regulate cardiomyocyte cell cycle activity

· Methods to activate microRNAs that control cell cycle activity in cardiomyocytes.

· Further develop age and endurance of iPSC-CM

· HiPS-CMs 3D tissue for direct cell substitution

· Other cell treatments like Vehicle Lymphocytes, MSC, and Dream cells.

· Recognize the job of safe cells in cardiomyocyte endurance and cardiovascular recovery

Cardiovascular pharmacology deals with the drugs used for the treatment of cardiac diseases. Cardiac Drugs are used to treat heart conditions or the circulatory or vascular system. The pharmaceutical industry has played an important role in advancing new medications for the treatment of cardiovascular disease, and certainly, there are more significant benefits in order to treat patients. In this sub-topic, we have ACE inhibitors, Sodium, potassium, calcium channel blockers, and Cardiac biomarkers. There are 6 associations and societies for Cardiac Therapeutic Agents in the USA. 50 universities are working on Cardiac Therapeutic Agents. Recently new drug named Entresto (ARNI) is a combination of two compounds that reduces the risk of cardiovascular death.

SUBTOPICS:

· Pharmacology and Pharmacotherapy

· Cardiovascular Pharmacotherapy

· Anticoagulants

· Antiplatelet Drugs

· Diuretics

· Nitrates

· Lipid-Lowering Agents

· Anti-Diabetic Pharmacotherapy

A healthy diet and lifestyle are the best weapons to fight against cardiovascular disease. It’s important to eat plenty of heart-healthy foods, which include fruits and vegetables, and foods that are rich in fiber and Omega-3 fatty acids. The overall goal of this diet is to reduce sodium and fat intake. Too much sodium can increase your blood pressure and it will lead to hypertension. Hypertension is the major risk factor of cardiac attack and other heart problems.

Abdominal Obesity	Alternative Medicine Antioxidants	Eggs and heart disease	Infant Nutrition International Dietary Guidelines
Adolescence	Binge Eating	Exercise	Macronutrients Multivitamins
Childhood Obesity	BMI, Fitness, Sports Nutrition	Fish and Seafood Recipes	Nutrition Education & Assistance Programs
Aging, Alcohol, Food Poisoning	Breast Cancer, Blood Cholesterol Levels	Food Labelling	Organic Foods, Osteoporosis, Agrochemicals and Cardiovascular Disease
AIDS/HIV, Nutrition Misinformation	Breastfeeding Bulimia	Food Science & Technology	Reports, Studies, and Statistics & Research
Allergies & Food Sensitivities	Digestive & Associated Disorders	Food Nutrition Surveys	Type 2 Diabetes, Unsaturated Fats, Herbal Information
Anorexia Nervosa	Disordered Eating, Protein	Heart Health	Water, Weight Control WIC

As we all are aware the infection COVID -19 which is spread all over the world caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though it primarily affects the respiratory system, it can also cause cardiovascular complications. Patients with pre-existing cardiovascular problems are at major risk for severity of illness and mortality. According to the survey and case reports, we understand that more than 40% of the Covid -19 patients are affected by cardiovascular diseases. Fatality rates for comorbid patients are more than the average population.

Scope and Research work to be discussed about this topic are:

· From the epidemiological proof base for post-Coronavirus cardiovascular difficulties.

· Create risk algorithms to figure out who needs ongoing support and who is at long-term cardiovascular risk.

· Look at the determinants of cardiopulmonary appearances post-Coronavirus.

· Assess potential atomic and cell processes that support long-haul heart difficulties connected with Coronavirus.

· Bring issues to light of the predispositions in revealing and contextualizing this for general society and mainstream researchers.

· Energize mediation preliminaries both in the intense and present intense setting on assess treatments designated at decreasing medium and long haul heart signs and results.

· Incentivize research into COVID-19-related cardiovascular complications in underrepresented groups (children, pregnant women, and those from low socioeconomic backgrounds).

· Assess the aberrant effect of the Coronavirus pandemic on cardiovascular well-being and weight scourge and research the effect of conduct mediations on long-haul heart well-being.

Cardiology is a branch of medicine that deals with the disorders and circulatory system of the heart. It includes the diagnosis and treatment of heart defects, heart failure and electrophysiology. Compared to last year, this year the number of case reports on cardiology as increased as the number of patients undergoing cardiac conditions are higher. So, this type of cardiology conferences will help in knowing in depth about the cardiac situation and research in this field all over the world through networking, B2B partnering between professionals and academicians. Cardiology conferences are very important for the common people to be aware of the cardiac conditions in the human body.

Some of the latest research works were done:

· Circumferential Pneumonic Vein Separation With versus Without Extra Low-Voltage-Region Removal

· Coronary Atherosclerotic Plaque Action and Future Coronary Occasions

· Percutaneous Microaxial Left Ventricular Help Gadget for Patients With Cardiogenic Shock

· Moderating Cardiovascular Sickness Hazard in Type 2 Diabetes and Ongoing Kidney Illness

· Dyspnea During Heart Catheterization

· Proof Age for Novel Cardiovascular Gadgets

More to be discussed in this session. Kindly join us with the new and interesting research works.

In the vision of 2021, several new technologies have come to profit cardiac care. Current trends by the treatment of CVD revolve around heart rhythm and cardiovascular tissue generation. The treatments mainly include devices for heart rhythm management, coronary failure , tissue engineering & 3D bioprinting. Innovations in surgery such as transcatheter ablation since it sheds light on other approaches and kinds of treatment currently available for various CVDs.

SUBTOPICS:

· Cardiac Biomarkers

· Cardiac Enzymes

· Cardiac ischemia

· Diagnose, Evaluate, and Monitor on cardiac biomarker

Sports Cardiology is said with the cardiovascular care of athletes and exercise cardiology is said to the individuals of all the age groups. Sports cardiology also includes the guts screening which helps to detect serious cardiovascular issues in young athletes. the most reason for death in exercising young athletes is Sudden asystole . This is often activated by a malignant tachyarrhythmia, for instance , fibrillation (VF) or ventricular tachycardia deteriorating into VF. Cardiologists confront various difficulties in assessing the athletes due to complex individual cardiovascular demand and adaptations forced by exercise. The most aim of the Sports Cardiology Center is to figure with any athlete forward the range - proficient athlete, recreational exercisers, to finish of the week warriors to enable them to realize these goals.

SUBTOPICS:

· Cardiovascular epidemiology & population science

· Improving ECG interpretation in athletes

· Circadian rhythm

· Cardiovascular assessment

· Sports and disorder Patient-centered counseling

· Cardiac exercise science

· Exercise stress testing

· Sudden cardiac death in sports

An Echo-cardiogram, often mentioned as a cardiac echo or just an echo, maybe a sonogram of the heart. Echo-cardiography commonly uses two-dimensional, three-dimensional, and Doppler ultrasound to capture the structure of the heart.

Echo-cardiography has become a routinely utilized technique in the diagnosis, management, and follow-up of patients with any suspected or known heart diseases. it's one of the foremost widely used diagnostic tests in cardiology. It can provide a wealth of helpful information, including the dimensions and heart shape (internal chamber size quantification), pumping capacity, and therefore the location and extent of any tissue damage. An echocardiogram can give physicians an estimation of heart function, like a calculation of the flow, ejection fraction, and diastolic function.

SUBTOPICS:

· Atrial fibrillation

· Supra-ventricular tachycardia

· Ventricular tachycardia

· Heart block

· Tachy-Brady syndrome

· Ventricular fibrillation

· Cardio-version

Cardiothoracic surgery includes the treatment and conditions of the heart, lungs, and chest. Our Surgeons perform a selection of cardiothoracic surgeries, from minimally invasive to heart transplants. Modern surgery has developed to a certain range that the body of knowledge and technical skills needed have to lead the Surgeons to specialize in particular areas, sometimes anatomical space of the body or sometimes during a selected technique or sort of a patient. Many Cardiological research laboratories are working to advance the understanding of the mechanisms of atrial fibrillation and to implement and develop potential therapies to treat atrial fibrillation and other forms of tachycardia.

Types of heart surgery:

· Arteria coronaria bypass grafting

· Heart valve repair or replacement

· Pacemaker Insertion or cardioverter defibrillator (ICD)

· Maze surgery

· Aneurysm repair

· Heart transplant

· Ventricular assist device (VAD) or total implant (TAH) insertion

· OPCAB Surgery

· Stented and stentless valves

· Endovascular stent placement

· Atrial fibrillation

· Transplantation

· Percutaneous valve repair/replacement

· Left ventricular restoration surgery

· Immunobiology

· Bridges to transplant and recovery

This convention focuses on the contrast of the fetal coronary heart with ultrasound imaging, which includes evaluation of structural and useful elements of the fetal cardiovascular machine and fetoplacental circulation.

This Cardiology Conference will overview present-day information and advances in fetal cardiac imaging and care that have an effect on the detection and administration of cardiovascular sickness in the fetus. The layout will encompass lectures, case displays, and interactive panel discussions.

The focal point will consist of an evaluation of fetal hemodynamic derangements in non-primary cardiac disease, determinants of fetal neurodevelopment, complete fetal care (inclusive of counseling, multidisciplinary coronary heart software mannequin, and trainee education), healthcare disparities in fetal cardiac care, and modern-day advances and improvements in fetal cardiology which includes early gestation and 3D fetal imaging, maternal hyper-oxygenation and far off fetal medicine.

SUBTOPICS:

· Echocardiography

· Fetal Problems

· Prenatal Diagnosis

· Tricuspid Insufficiency

· NeonatesCongenital Heart Disease

· Fetal Heart Tumor

· Pediatric Cardiology

Cardiac imaging is a diagnostic radiology specialization. A cardiac radiologist supervises or performs medical imaging and then interprets the results to identify heart disorders such as heart disease, leaky heart valves, and heart size and shape problems.

There was a watershed area between radiology and cardiology in the early days of cardiac imaging development. While radiologists invented and developed cardiac and coronary angiography, the role of the radiologist in performing cardiac catheterization and coronary angiography has gradually diminished. The prominence of echocardiography as the primary non-invasive first-line assessment of heart illness has further limited the function of the radiologist.

The rising frequency of cardiovascular disorders in developing regions such as South America and Asia, according to market experts, is fueling market expansion. The global Cardiac Imaging market is expected to grow at a CAGR of percent between 2021 and 2027, from USD million in 2020 to USD million in 2027.

Subtopics:

· Echocardiography

· Intraoperative and Interventional Echocardiography

· Computed Tomography

· Coronary CT Angiography

· Cardiac Magnetic Resonance

· Nuclear Imaging

Dyslipidemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027 is a recent study from Transparency Market Research (TMR). The report estimates that the market for pharmaceuticals to treat dyslipidemia was worth US$ 11.8 billion in 2018 and would grow at a CAGR of 3.5% from 2019 to 2027. From 2019 to 2027, rising illness awareness thanks to promotional campaigns and an increase in the prevalence of people with abnormal cholesterol and triglyceride levels will be the key market drivers for dyslipidemia medications worldwide.

SUBTOPICS:

· Epidemiology of cardiovascular diseases and risk factors

· Epidemiology of dyslipidemias

· Diabetes, insulin sensitivity and resistance

· Adipose tissue homeostasis

· Inherited dyslipidemias

· Gender and cardiovascular risk

· Environmental risk factors

· Novel risk factors and biomarkers

· Epidemiology of socioeconomic and psychosocial risk factors

· Coagulation

· Gut microbiome

· Gene editing technology

· Genomics, GWAS and population genetics; Mendelian randomization

· Epigenetics and microRNA

· Gene-Environment interactions

The market for arrhythmias was estimated to be worth USD 6.39 billion in 2021 and is anticipated to expand at a CAGR of 6.8% during the next five years. Increased incidences of unhealthy lifestyle choices including smoking, binge drinking, and obesity (which make a person more susceptible to cardiac arrhythmias) as well as rising patient awareness levels are driving the industry's growth. According to a survey by Acumen Research and Consulting, the global market for cardiac arrhythmia monitoring devices, which was valued at USD 6,485 million in 2021, is anticipated to grow to USD 11,490 million by 2030, with a sizable CAGR of 6.8% from 2022 to 2030.

SUBTOPICS:

· Arrhythmias, General – Treatment

· Atrial Fibrillation

· Atrial Fibrillation - Epidemiology, Prognosis, Outcome

· Atrial Fibrillation - Treatment

· Atrial Fibrillation - Stroke Prevention

· Supraventricular Tachycardia (non-AF)

· Supraventricular Tachycardia (non-AF) - Pathophysiology and Mechanisms

· Supraventricular Tachycardia (non-AF) - Epidemiology, Prognosis, Outcome

· Supraventricular Tachycardia (non-AF) - Diagnostic Methods

· Supraventricular Tachycardia (non-AF) - Treatment

· Supraventricular Tachycardia (non-AF) - Prevention

· Supraventricular Tachycardia (non-AF) - Clinical

· Syncope and Bradycardia

· Syncope and Bradycardia - Pathophysiology and Mechanisms

· Bradycardia - AV-Block

· Tachycardia

· Non-arrhythmogenic Mechanisms of Syncope

· Syncope and Bradycardia - Epidemiology, Prognosis, Outcome

· Syncope and Bradycardia - Diagnostic Methods

· Syncope and Bradycardia - Treatment

· Drug Treatment

· Pacemaker Therapy

· Syncope and Bradycardia - Clinical

· Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

· Ventricular Arrhythmias and SCD - Epidemiology, Prognosis, Outcome

· Ventricular Arrhythmias and SCD - Treatment

· Management of Out of Hospital Cardiac Arrest

· Device Treatment of Ventricular Arrhythmias and SCD

· Ventricular Arrhythmias and SCD - Clinical

· Device Therapy

· Device Complications and Lead Extraction

The market for heart transplants was valued at USD 9,926.86 million in 2021, and it is anticipated to grow significantly over the forecast period of 2022–2030, by 10.10%, to reach USD 15,813.98 million. During the forecast period, the worldwide heart transplant market is expected to expand at a noteworthy CAGR of 10.3%. The increasing incidence of heart failure fuels the need for effective treatment strategies, which in turn fuels market expansion.

Advanced Heart Failure and Transplantation (HEART)

· HEART–Access to Care/Caregiver

· HEART–Basic Science-Immunology, Inflammation

· HEART–Basic Science-Models of Organ Preservation, Perfusion and Graft Injury

· HEART–Basic Science-Translational Research/Other

· HEART–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs

· HEART–Cardiac Allograft Vasculopathy

· HEART–Cardiogenic Shock

· HEART–Clinical Ex-Vivo Perfusion and Preservation

· HEART–Compliance/Adherence/Psychosocial Aspects

· HEART–Complications Other

· HEART–Congenital Heart Disease Management

· HEART–COVID-19 Vaccine Pre- and Post-Transplant

· HEART–COVID-19 Non-Vaccine related

· HEART–Critical Care Medicine/Peri-operative/Intra-operative Management

· HEART–Diagnostics/Patient Management/Patient Care Pathways

· HEART–Donor Management

· HEART–Economics, Ethics, Public Policy/Health Equity

· HEART–Immunology, Inflammation (Clinical)

· HEART–Infectious Diseases - Diagnostics and Complications

· HEART–Infectious Diseases - Management and Therapeutics

· HEART–Organ Allocation

· HEART–Other (Clinical)

· HEART–Outcomes (Effectiveness)

· HEART–Outcomes (Other)

· HEART–Outcomes (Risk Prediction/Modelling)

· HEART–Outcomes (Safety)

· HEART–Palliative Care/Self Care/Symptom Management

· HEART–Pathology

· HEART–Patient Selection for Advanced Therapies/Rehabilitation

· HEART–Pediatrics-Basic and Translational Research

· HEART–Pediatrics-Complications

· HEART–Pediatrics-Heart Failure

· HEART–Pediatrics-Other

· HEART–Pediatrics-Outcomes

· HEART–Pediatrics-Patient Selection, Organ Allocation, Donor Management

· HEART–Pharmacology, Therapeutics, Immunosuppression

· HEART–Primary Graft Dysfunction

· HEART–Quality of Life/Quality Improvement

· HEART–Rejection-Antibody Mediated (AMR)

· HEART–Rejection-Cellular

· HEART–Telehealth/Remote Monitoring and Interventions

Advanced Lung Failure and Transplantation (LUNG)

· LUNG–Basic Science-Immunology, Inflammation

· LUNG–Basic Science-Organ Preservation, Perfusion and Graft Injury

· LUNG–Basic Science-Translational Research/Other

· LUNG–Basic Science-Xenotransplantation/Regenerative Medicine/Artificial Organs

· LUNG–Caregiver and Psychosocial Aspects/Adherence to Care

· LUNG–Chronic Lung Allograft Dysfunction (CLAD)

· LUNG–Clinical Ex-Vivo Perfusion and Preservation

· LUNG–COVID-19

· LUNG–Critical Care Medicine/Peri-operative Care

· LUNG–Diagnostics and Pathology

· LUNG–Donor Management and Organ Allocation

· LUNG–ECLS/Short-Term Support

· LUNG–Economics, Ethics, Public Policy

· LUNG–Immunology, Inflammation (Clinical)

· LUNG–Infectious Diseases

· LUNG–Other/Complications (Clinical)

· LUNG–Palliative Care/Symptom Management

· LUNG–Pediatrics

· LUNG–Pharmacology, Therapeutics, Immunosuppression

· LUNG–Primary Graft Dysfunction

· LUNG–Quality Improvement/Service Development/Access to Care

· LUNG–Quality of Life/Frailty/Patient Reported Outcomes

· LUNG–Recipient Selection for Transplant and/or Advanced Therapies

· LUNG–Rejection (Acute)

· LUNG–Surgical Aspects of Lung Transplantation

· LUNG–Survival/Prognostication

In 2021, the 7MM cardiomyopathies market was valued at approximately $1.6 billion. During the forecast period, a CAGR of more than 12% is anticipated for the market. The United States contributes the most to that revenue. The United States, France, Germany, Italy, the United Kingdom, Spain, and Japan dominate the cardiomyopathies market. The cardiomyopathies market has the highest sales in the United States.

SUBTOPICS:

· Hypertrophic Cardiomyopathy

· Dilated Cardiomyopathy

· Restrictive Cardiomyopathy

· Arrhythmogenic Right Ventricular Dysplasia

· Alcoholic cardiomyopathy

· Congestive cardiomyopathy.

· Diabetic cardiomyopathy.

· Familial dilated cardiomyopathy.

· Idiopathic cardiomyopathy.

· Ischemic cardiomyopathy

· Peripartum cardiomyopathy.

· Primary cardiomyopathy.

· Asymmetric septal hypertrophy

· Familial hypertrophic cardiomyopathy

· Hypertrophic nonobstructive cardiomyopathy

· Hypertrophic obstructive cardiomyopathy

· Idiopathic hypertrophic subaortic stenosis

· Idiopathic restrictive cardiomyopathy

· Infiltrative cardiomyopathy

· Arrhythmogenic right ventricular cardiomyopathy

· Right ventricular cardiomyopathy

· Right ventricular dysplasia

The cardiac surgical devices market was worth USD 26,660.19 million in 2021 and is expected to reach USD 46,701.27 million by 2030, expanding at a CAGR of 6.38% between 2022 and 2030. The market for cerebral embolic protection devices is expected to grow at the fastest rate in the global cardiac surgery market in 2021, reaching over $14.2 billion. In spite of COVID-19, the global market is anticipated to reach over $20.4 billion by 2027.

SUBTOPICS:

· Aortic Surgery

· Cardiac Surgery and Arrhythmias

· Cardiac Surgery and CHD and Pediatrics

· Cardiac Surgery and Heart Failure

· Cardiac Surgery and SIHD

· Cardiac Surgery and VHD

· Vascular Surgery

· Coronary artery bypass grafting (CABG)

· Heart valve repair or replacement

· Insertion of a pacemaker or an implantable cardioverter-defibrillator (ICD).

· Maze surgery

· Aneurysm repair

· Insertion of a ventricular assist device (VAD) or total artificial heart (TAH)

· Abdominal Surgery

· Experimental Surgery

4th International Conference on Cardiology

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at

4th International Conference on Cardiology

1Cardiovascular Diseases

2Heart Diagnosis

3Cardiac and Cardiovascular Research

4Heart Devices

5Cardiovascular Diabetology, Obesity & Stroke

6Interventional Cardiology

7Nuclear Cardiology, Molecular Cardiology, Cardio-Oncology

8Pediatric Cardiology & Womens Cardiology

9Cardiac Nursing Care

10Heart Regeneration

11Cardiac Pharmacology

12Cardiac Diet/Cardiac Nutrition

13Cardiovascular Impact of COVID-19

14Current Research and Advances in Cardiology & Case Reports on Cardiology

15Cardiology - Future Medicine

16Sports Cardiology

17Echocardiology and Valvular Diseases

18Cardiothoracic Surgery

19Fetal Cardiology

20Cardiac Imaging

21Dyslipidemia and Risk factors

22Cardiac Arrhythmias

23Transplantation: Heart and Lungs

24Cardiomyopathies

25Cardiac Surgery

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at